Swixx BioPharma
Swixx BioPharma
Swixx BioPharma is a specialized distributor of rare diseases, Rx and OTC medicinal products in Central & Eastern Europe, and acts as a true commercialization partner for Biotech & Pharma companies in this area.
Swiss firm Swixx registers new drug for lymphoma in Russian market
The Company Statement
March 28, 2023
The American company Eli Lilly will transfer its Russian business to the Swiss company Swixx Biopharma. Previously, Swixx Biopharma received the business of another American pharmaceutical company, Bristol-Myers Squibb (BMS). The American Eli Lilly banned the Swiss Swixx BioPharma, which a year ago bought Eli Lilly’s business in Russia, from supplying Humalog insulin to the country.
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner